PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q1 2023. The put-call ratio across all filers is 8.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,727 | -1.1% | 82,727 | +34.7% | 0.04% | -18.9% |
| Q2 2023 | $175,647 | -81.7% | 61,415 | -81.4% | 0.05% | -88.3% |
| Q1 2023 | $962,320 | -0.7% | 330,694 | 0.0% | 0.45% | +47.9% |
| Q4 2022 | $968,933 | +22.0% | 330,694 | 0.0% | 0.31% | +46.9% |
| Q3 2022 | $794,000 | +3.4% | 330,694 | -3.6% | 0.21% | -4.1% |
| Q2 2022 | $768,000 | +8.0% | 342,994 | +10.9% | 0.22% | +40.6% |
| Q1 2022 | $711,000 | +9.9% | 309,294 | +19.6% | 0.16% | +78.2% |
| Q4 2021 | $647,000 | – | 258,694 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,217,828 | $3,045,000 | 0.44% |
| Ayrton Capital LLC | 153,130 | $383,000 | 0.36% |
| Shay Capital LLC | 662,337 | $1,656,000 | 0.27% |
| EQUITEC PROPRIETARY MARKETS, LLC | 258,694 | $647,000 | 0.09% |
| Anson Funds Management LP | 193,400 | $484,000 | 0.05% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 44,944 | $112,000 | 0.00% |
| Jump Financial, LLC | 10,300 | $26,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 30,400 | $76,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,763 | $5,000 | 0.00% |